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POPULÄRVETENSKAPLIG SAMMANFATTNING 
I denna avhandling redovisas olika metoder för att mäta exponeringen för miljögifterna 
polyklorerade bifenyler (PCB), polyklorerade dibenzo-p-dioxiner och polyklorerade 
dibenzofuraner (PCDD/F) i olika grupper av befolkningen. 
PCBer är industrikemikalier som framställts främst för användning i elektrisk 
apparatur. PCDD/F bildas framförallt oavsiktligt vid förbränning. Under 1970-talet 
förbjöds användningen av PCB i många länder på grund av risken för negativa 
hälsoeffekter hos djur och människor vid exponering för PCB och PCDD/F.  
Våra undersökningar visade att ammade spädbarn har 11 gånger högre exponering för 
PCB och PCDD/F, beräknat utifrån halter uppmätta bröstmjölk, än barn 1-3 år gamla 
beräknat med hjälp av kostenkäter och uppmätta halter i livsmedel. Exponeringen 
uttryckt per kg kroppsvikt sjönk med stigande ålder, upp till vuxen ålder (ca 70% 
minskning). Fisk och fiskprodukter var den största källan till exponering hos både barn 
och vuxna, följt av mejeri- och köttprodukter. De två exponeringsmodeller som vi 
använt, så kallad deterministisk och probabilistisk, gav liknande resultat med avseende 
på den genomsnittliga exponeringen. Den deterministiska modellen gav dock ett högre 
exponeringsmått (överskattar exponeringen) hos högexponerade. Vi testade även hur 
väl en kostenkät kan spegla individuell exponering från kosten. Resultaten visade att 
enkäten var användbar för att beräkna exponeringen för PCB som vi kunde använda för 
att skatta risken för hjärtinfarkt hos kvinnor (48 – 83 år). Kvinnor med en 
genomsnittlige exponering på 280 ng PCB/dag hade 70% större risk att drabbas av 
hjärtinfarkt än kvinnor med en exponering på 98 ng PCB/dag. Hjärtinfarkt med dödlig 
utgång var ca två gånger högre hos de högst exponerade kvinnorna jämfört med 
kvinnor med låg exponering.   
Sedan förbudet mot PCB infördes, för ca 30 år sedan, har halterna av PCB och 
PCDD/F sjunkit både i miljön och hos människor men det finns indikationer på att 
halterna inte minskar längre. Resultaten från denna avhandling tyder på att 
exponeringen för PCB och PCDD/F fortfarande kan utgöra ett hot mot människans 
hälsa. Därför är det viktigt att karakterisera exponeringen i känsliga grupper av 
befolkningen med hjälp av olika exponeringsmodeller, och att åtgärder för eliminering 
eller reducering av exponeringskällor fortsätter.  
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ABSTRACT 
Humans are exposed to a variety of potentially harmful contaminants on a daily basis. 
Characterizing the exposure in different subgroups of the general population is 
important in order to protect public health sufficiently.  
The overall aim of this thesis was to refine human exposure assessment by applying 
different methodological approaches for characterizing the exposure to harmful 
contaminants such as polychlorinated biphenyls (PCBs), dibenzo-p-dioxins and 
dibenzofurans (PCDD/Fs) in different subgroups of the Swedish general population. 
We assessed the exposure to PCBs and PCDD/Fs in breastfed infants (up to 6 months 
of age), children and adolescents (1 – 24 year of age) and first-time mothers based on 
food consumption data (1989) and contaminant concentrations in food (1998 - 2004) 
and breast milk (2000 - 2006). A food concentration database was developed for the 
assessment of food frequency questionnaire (FFQ)-based PCB153 exposure in 
middle-aged and elderly women (born 1914 - 1948). 
Median exposure to PCBs and PCDD/Fs declined from 44 pg/kg body weight in 1 
month old breastfed infants to less than 1.4 pg/kg body weight in adults 15 - 40 years of 
age. The proportion of individuals exceeding the current TDI of 2 pg TEQ/kg body 
weight decreased from 100% in infants and young children to less than 26% in adults. 
Mean exposure to PCBs and PCDD/Fs was comparable when using either the 
probabilistic or the deterministic approach, whereas the deterministic worst-case 
scenario estimate was up to 1.7 times higher than the probabilistic estimated 95
th
 
percentile. We obtained a reasonable validity of the FFQ for estimating concurrent 
(Spearman correlation rs 0.37; p<0.001) and long-term (rs 0.32; p<0.05) dietary PCB153 
exposure assessment against serum PCB153 concentrations. Based on the validated 
FFQ we found a significantly increased risk (hazard ratio 1.67; 95% CI 1.17 – 2.40) of 
myocardial infarction in middle-aged and elderly women of the highest exposure group 
(median 280 ng/day) compared to the lowest (median 98 ng/day) using a Cox 
regression model. Highly exposed individuals were characterized by a high fish 
consumption independent of age. A high dietary PCB153 exposure and a low intake of 
fish fatty acids (<0.20 g/day of EPA - DHA) were associated with a greater risk of 
myocardial infarction (hazard ratio 2.22; 95% CI 1.25 to 3.94) compared to a low 
exposure and a high intake of EPA and DHA (> 0.29 g/day). Thus, continued actions 
are needed to reduce environmental levels and at the same time conduct risk-benefit 
analysis for efficient dietary recommendations. 
This thesis provides new and detailed knowledge of exposure to environmental 
contaminants in different subgroups of the population by using different 
methodological approaches, necessary to increase the precision in the exposure 
estimates. Refining the exposure assessment is a prerequisite for sustaining public 
health. 
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1 INTRODUCTION 
 
Humans are exposed to contaminants on a daily basis via food, air, water and 
consumer products. Exposure can lead to deleterious health effects depending on the 
inherent properties of the chemical and the degree of contact, the frequency and the 
duration of exposure, as well as the individual characteristics such as behavior and 
physiological factors. Hence, the exposure distribution in a population may vary 
between different population subgroups including children, pregnant women and 
elderly. Characterizing the exposure in different subgroups of the population is 
important in order to be able to sufficiently protect them from harmful contaminants, 
thereby maintaining public health and well-being in the community. Hence, 
knowledge of the exposure is the basic prerequisite for risk reduction.  
 
Human exposure assessments are performed for different purposes, including human 
health risk assessment, epidemiology, status and trends analysis, and risk management, 
all of which rely on reliable exposure data (Figure 1).  
 
 
 
 
 
 
Figure 1. Components of human exposure assessment and the role of exposure assessment in 
different fields. 
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2 BACKGROUND 
2.1 Human exposure assessment  
Exposure can be defined as the contact over time between contaminants and a human, 
whereas exposure assessment is the process of estimating or measuring the 
magnitude, frequency, duration, and route of exposure to the contaminants along with 
the number and characteristics of the population of interest.
1
  
 
Human exposure assessment can be approached in two ways; directly and indirectly. 
A direct approach involves personal exposure monitoring and biological monitoring, 
also called biomonitoring, which includes measurements of a contaminant or its 
metabolites in suitable human media such as blood, urine or breast milk.
1
 An indirect 
approach involves questionnaires, data modeling and environmental monitoring, 
which includes measurements of a contaminant in food, water, air, soil and plants.
1
 
The choice of approach depends on the purpose of the study, the data availability and 
data quality that is needed to address the questions of interest. It is often useful to 
combine two or more approaches to gain as much information as possible.  
 
 
 
2.1.1 Direct exposure assessment approaches 
 
Biomonitoring is the measurement of environmental substances including contaminants 
in a biological media such as blood and breast milk, and has been used extensively to 
assess and monitor the exposure to contaminants in humans. Biomarkers of exposure 
take into account both intra- and inter-individual differences in exposure and may give 
a more precise measurement of the internal dose integrated over all exposure sources.
1
  
The disadvantage, however, is that biomonitoring is often expensive to perform due to 
the high costs of sampling and chemical analyses of biomarkers of exposure, resulting 
in restricted sample sizes, which in turn can lead to discrepancies in results between 
studies because of low statistical power and chance. Furthermore, to obtain reliable 
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biomarkers of exposure knowledge about the relationship between exposure and 
internal dose is necessary. 
 
 
 
2.1.2 Indirect exposure assessment approaches 
2.1.2.1 Dietary questionnaires 
Well-designed dietary questionnaires are used for assessing individuals‟ food 
consumption. The dietary record method is based on the participants‟ records of the 
amount and the type of food and beverages that are consumed over one or more days.
2
 
The amounts consumed are reported in terms of household measures or estimated based 
on pictures or models of portion sizes.
3
 Theoretically, dietary records give an accurate 
estimate of the amount of food consumed and minimize errors such as recall bias 
because the information is recorded at the time of the eating occasion. The 
disadvantage with dietary records is the high number of days required in order to 
capture the average consumption or seasonal variation in dietary habits, which 
increases respondent burden.
3
 This relatively high burden requires that the respondent 
is motivated otherwise it can i) lead to a risk of incomplete records with increasing 
number of consecutive days of recording and/or ii) lead to altered dietary habits as the 
respondent may modify the diet in order to decrease the burden of recording, resulting 
in an under- or overestimation of intakes, and thus limiting the generalizability of the 
results. In dietary recording there is also a risk that the respondents report a lower 
consumption of unhealthy foods, such as desserts and alcohol and a higher 
consumption of healthy foods such as grains, salads and vegetables in order to report a 
socially desirable diet.
3
   
 
Food frequency questionnaires (FFQs), on the other hand, record the average food 
consumption over a longer period of time.
2
 The respondents are asked about their usual 
frequency of food consumption from a food list. The FFQs can also include portion 
sizes such as number of glasses or slices for some foods or beverages. Otherwise the 
consumption frequencies are multiplied with standard portion sizes to obtain an 
estimate of the amount of food consumed.  
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FFQs are relatively easy to use for obtaining information of an individual‟s usual 
dietary consumption and are cost-effective in comparison to other methods such as 
measurements of biomarkers of exposure. The disadvantages with FFQs are; i) the food 
list, that is supposed to cover the usual consumption of the respondents, may lack some 
important foods or beverages, ii) the number of questions asked can influence the 
reported consumption,
4
 iii) misreporting by the participants due to recall bias or by 
overestimating “healthy” food and underestimating foods such as sweets and alcohol, 
and iv) the standard portion-sizes assigned to the consumption frequencies may not 
represent the respondent‟s usual portion sizes.3  
 
 
 
2.1.2.2 Data modeling 
Most exposure assessments rely, to some extent, on exposure models that combine 
measurements and assumptions to produce an estimate of the exposure to a 
contaminant or chemical.
5
 An exposure model is a computational frame-work designed 
to reflect real-world human exposure scenarios.   
 
Exposure to contaminants through the diet can be estimated by combining data on food 
consumption with concentration data of contaminants in the food and/or food groups.
6
 
The approaches for estimating such exposure include the deterministic, the simple 
distribution and the probabilistic approach.  
 
The deterministic approach relies on point estimates of each input variable and refers 
to a method whereby fixed values, e.g., the average, of food consumption and of the 
concentration data on contaminants in food are combined in order to obtain a single 
estimated exposure value.
7
 A worst case scenario approach is typically based on point 
estimates covering the upper-bounds of exposure, i.e., 95
th
 or 99
th
 percentile or the 
maximum value, in order to protect public health. Consequently, the deterministic 
approach assumes that all individuals consume the same amount of food and that the 
pollutant is always present at a constant level in the particular exposure media. 
Though, an advantage with the deterministic approach is that it is time-efficient and 
will easily give a rough estimate of the exposure.  
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The deterministic approach is conservative and does not take into account variability, 
which is the natural inherent difference in data. The simple distribution approach, also 
known as range estimates, often employs a distribution for the food consumption 
data, whereas the concentration data on contaminants in food is appointed a fixed 
value.
7
 Simple distributions take into account the variability that is inherent in the 
pattern of the consumption data resulting in a distribution of the exposure, which is 
more informative than the exposure estimated by the deterministic approach. 
Nonetheless, conservative assumptions are still related to the presence of the 
contaminants in food.  
 
The probabilistic approach, on the other hand, applies probability density functions to 
the food consumption and contaminant concentration data since it is often not practical 
to measure the exposure for every person in a population.
8
 Within the probabilistic 
exposure model, simulations of exposure (e.g. Monte Carlo simulations) are carried 
out by randomly selecting values from the probability distributions where every 
possible value is weighed by the probability of its occurrence. The probabilistic 
exposure model is run several times generating new exposure estimates (Figure 2). By 
considering the whole distribution of the exposure, the probabilistic approach ensures 
that the variability and/or uncertainty, which is the lack of knowledge about the correct 
value for a specific exposure measure or estimate, are reflected in the output of the 
exposure model.
8
  
 
One way to quantify the uncertainty is to use the bootstrap method, a statistical 
technique based on multiple resampling with replacement of the sample values or of 
the sample distributions resulting in a confidence interval around the statistics.  
Sensitivity analysis is a useful technique to identify variables that have the greatest 
effect on the variance of the outcome in an exposure model. The results from a 
sensitivity analysis can be useful as an underlying basis for an uncertainty analysis by 
providing with information about the variables.
8
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Figure 2. Schematic view of the probabilistic exposure assessment model. 
 
 
 
 
 
2.1.3 Left censored data 
A difficult step in dietary exposure assessment is the handling of analytical 
concentration data below the quantification limit, known as non-detects, resulting in a 
left-censored distribution of occurrence values. The level of censoring is based on the 
confidence with which the analytical signal can be discerned from the noise. 
Censored data are measurable but the quantity is uncertain, i.e., the quantification 
limit is the lowest level at which a chemical may be accurately and reproducibly 
quantified.  
 
There are numerous ways of dealing with values below the quantification limit and, so 
far, there is no one procedure that outweighs all other procedures for various exposure 
assessment circumstances. Techniques for analyzing censored data sets include 
substitution methods, log-probit regression methods, maximum likelihood estimation 
methods (MLE) and non-parametric methods.
9
 The substitution method is the most 
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commonly encountered technique and includes ignoring the censored data, replacing 
censored data with zero, replacing censored data with the quantification limit or 
replacing censored data with one-half of the quantification limit.
10
 It has been widely 
recognized that the substitution method is biased; the bias being a function of true 
variability in the data, the percentage of censored observations and the sample size.
9
 
The MLE method makes use of the data above the quantification limit to extrapolate 
below it. Data below and above the quantification limit are assumed to follow a given 
statistical distribution. The parameters of the chosen distribution are estimated to best 
fit the distribution of the observed values above the quantification limit, compatibly 
with the percentage of data below the limit. The estimated parameters are the ones 
that maximize the likelihood function.
9,11
 
  
 
 
2.2 Polychlorinated biphenyls, dibenzo-p-dioxins and dibenzofurans 
In this thesis, exposure to manufactured chemicals and unintentionally formed by-
products such as polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-
dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) was characterized. 
These contaminants are designated as persistent organic pollutants (POPs) and consist 
of 209, 75 and 135 congeners, respectively.
12
 The congeners are determined by their 
chlorine pattern on the biphenyl ring (Figure 3). These contaminants can persist in the 
environment for long periods of time due to their resistance to bio-degradation, and can 
travel long distances in the atmosphere and have been found in remote areas such as the 
Arctic.
13
 PCBs and PCDD/Fs also bioaccumulate and biomagnify up the food chain 
resulting in higher concentrations in species at the top of the chain. These contaminants 
may pose toxic threats to humans and wild-life resulting in endometrial, reproductive, 
immunological and carcinogenic health effects.
14
 The term „dioxins‟ includes 12 PCB 
congeners, often termed dioxinlike PCBs (DL-PCBs), and 17 PCDD/F congeners.
15
 
Dioxins are of special toxicological concern because they have similar properties as 
the most potent congener, 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD), which is 
classified as a known human carcinogen (Group 1) by the International Agency for 
Research on Cancer.
16
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Figure 3. Chemical structure of polychlorinated biphenyls (A), polychlorinated dibenzo-p-
dioxins (B), polychlorinated dibenzofurans (C). 
 
 
 
 
2.2.1  History of PCBs and PCDD/Fs 
Since the early 1930s, PCBs have been commercially manufactured as chemical 
mixtures under different trade names in the U.S., Japan, Germany, France, Spain, U.K., 
Italy, Czechoslovakia, Poland, Austria, Russia and China.
17
 PCBs have been used for a 
number of applications including transformers and capacitors where they were used as 
dielectric fluids, but also in building material (sealants), carbonless copy paper, 
lubricants, surface coatings, adhesives, plasticizers, and inks among other things.
18,19
 
Of the estimated 1.5 million metric tons of PCBs produced globally since the 1930s, 
one third is thought to have found its way into the environment, mainly in 
industrialized countries (Figure 4).
17,20
   
 
PCBs have never been produced in Sweden but the Swedish industry has imported 
PCBs from U.S., Germany, France and U.K.
21
 In 1972, Sweden took regulatory actions 
to restrict the use of PCBs to closed systems such as capacitors and transformers.
21
 In 
1985, a new law was passed stating that all use of PCBs should be phased out by 1995. 
In 2001, a global action (the Stockholm Convention Treaty initiated by the United 
Nations Environmental Programme) was taken to eliminate or restrict the production 
and use of POPs around the world.
22
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Figure 4. Concentrations of polychlorinated dibenzo-p-dioxins and polychlorinated 
dibenzofurans in breast milk expressed as toxic equivalence (TEQ) values (pg/g lipid weight). 
World map constructed with STATPLANET based on data from LaKind et al., 2007.
23
 
 
 
PCDD/Fs are formed as unintentional by-products during incomplete combustion 
processes such as in waste incinerators or as unwanted by-products of industrial 
processes. In Sweden, iron and steel production, as well as pulp and paper mills that 
use chlorine have been important sources of environmental PCDD/F contamination.
24
 
Waste and uncontrolled waste burning such as backyard burning, as well as secondary 
emissions from chlorophenol (PCP)-treated wood are ongoing sources of 
environmental contamination.  
  
Throughout the 1900s, several large incidents have been reported involving excessive 
exposure to PCBs and PCDD/Fs and their association with health effects in humans 
and animals.
25
 Among these incidents are the use of the contaminated herbicide 
Agent Orange as a defoliant during the Vietnam War in the 1960s,
26
 the explosion of 
the 2,4,5-trichlorophenol factory in Seveso (Italy 1976),
27
 the poisoning from edible 
rice oils in Japan (Yusho, 1968)
28
 and Taiwan (Yu-Cheng, 1978),
29
 and the poisoning 
incidences of food and animal feed (Ireland 2008; India 2007; Belgium 1999; Brazil 
1998; U.S. 1997).
25,30
 Studies from these incidents revealed and supported previous 
theories about the association between exposure to PCBs and/or PCDD/Fs and 
deleterious effects in humans such as carcinogenic, developmental, reproductive, 
dermal and cardiovascular effects.
27-29
 Monitoring concentrations of PCBs and 
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PCDD/Fs in food is an important step in detecting impurities at an early stage and to 
prevent the contaminants from reaching humans. 
 
 
 
2.2.2 PCBs and PCDD/Fs in the environment and food 
Over the subsequent decades, almost 30 years, since the use of PCBs was restricted in 
Sweden, the concentrations of PCBs and PCDD/Fs in the Swedish environment (swine, 
bovine, guillemot egg) have decreased by roughly 80%, but since the 1990s the rate of 
decline has been lower.
31,32
  
 
In the general population, diet constitutes more than 95% of the total exposure to PCBs 
and PCDD/Fs when taking into account other exposure routes such as dermal 
absorption, air inhalation, and soil and dust ingestion.
33
 At least 75% of the dietary 
exposure to PCBs is of animal origin,
34
 particularly fish and fish products which are the 
major food sources in Sweden 
35
 as well as in other countries such as Finland, Spain, 
Japan, and Belgium.
36-39
 
 
Because of the high concentrations of PCBs and PCDD/Fs in the diet and the fact that 
diet is the major source of exposure in the general population, the European 
Commission stipulates that levels of dioxins in foodstuffs should not, when placed on 
the market, exceed the maximum levels specified in the European regulations.
40
 
However, certain fish species originating from the Baltic region (herring and salmon) 
that contains high levels of dioxins often exceed these maximum levels. Excluding 
fish from the Baltic region from the Swedish and Finnish diet may have a negative 
health impact on the population because of the many nutrients in fish (including 
omega-3 fatty acids, selenium and vitamin D)
41
 and a negative effect on the fishing 
industry. In previous years, a temporary exemption has been granted for Sweden and 
Finland regarding the sale of Baltic-sourced fish but from 2012 this exemption will be 
permanent. At the same time, the Swedish National Food Agency (NFA) is obliged to 
inform consumers of the dietary recommendations concerning restrictions on 
consumption of fish from the Baltic region in order to avoid potential health effects in 
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the general population as well as in sensitive sub-groups such as girls and women of 
child-bearing age and pregnant women.
42
  
 
 
 
2.2.3 PCBs and PCDD/Fs in humans 
Once ingested through the diet, up to 100% of PCBs and PCDD/Fs are absorbed 
through the intestines of infants
43
 and between 48 and 99% is absorbed in adults.
44
 The 
absorption, by passive diffusion, is congener specific and depends on the molecular 
size, lipophilicity, composition of the food that is ingested together with the 
contaminants, and concentrations already present in blood.
44
 As with fats and other fat-
soluble chemicals, PCBs are most likely absorbed from the gut via the lymphatic 
circulation and finally deposited mainly in the adipose tissue.
45
 
 
The metabolism of dioxins is through the affinity to the aryl hydrocarbon receptor 
(AhR), whereas non-dioxinlike PCBs bind to several different receptors such as the  
constitutive androstane receptor (CAR)/pregnane X receptor (PXR), both inducing the 
transcription of cytochrome P450 (CYP) enzymes.
46,47
 Congeners of PCBs and 
PCDD/Fs accumulate in the human body with different persistence, reflected by the 
congener‟s half-life that can vary from a couple of months to several decades partly 
attributable to personal characteristics such as age, body fat, and lactation.
48
  
 
During pregnancy, concentrations of PCBs and PCDD/Fs are transferred from maternal 
blood to the blood of the fetus. During breastfeeding, PCBs and PCDD/Fs are 
eliminated from maternal stores to breast milk. The ratio of PCBs concentrations in 
cord blood, cord tissue and placenta compared to maternal blood is 0.6, 0.4 and 0.4, 
respectively, whereas the ratio for breast milk is 1.5.
49
 Several studies have found 
strong correlations between concentrations of PCBs and PCDD/Fs in mothers‟ blood, 
cord blood, placenta as well as between blood and adipose tissue.
50,51
  Suggested 
predictors of high concentrations of PCBs and PCDD/Fs in blood and breast milk are 
attributable to personal characteristics and life-style factors such as age, serum lipids, 
parity, duration of breastfeeding, fish consumption, body fat mass, early life exposure 
  
12 
 
to PCBs and PCDD/Fs, physical activity, place of residence, education and social 
class.
52
 
 
Since 1972, the concentrations of PCBs and PCDD/Fs in breast milk have decreased by 
at least 70% 
53
 and mirror the decrease in concentrations of PCBs and PCDD/Fs in food 
and in the environment. The amount of PCBs in the breast milk of Swedish mothers is 
estimated to represent two thirds of the total amount of chemicals present, a total which 
includes DDT, DDE, HCB and PBDE.
53
  
 
 
 
2.3 Human health risk assessment of PCBs and PCDD/Fs  
Human exposure assessment is one of four activities in health risk assessments of 
PCBs and PCDD/Fs the others being hazard identification, hazard characterization 
and risk characterization.
54
 Human health risk assessment, on the other hand, is a 
component in risk analysis together with risk communication and risk management.  
In the first activity, hazard identification, the type and nature of the health effect that 
a contaminant is capable of causing are typically identified from in vivo and in vitro 
studies. Hazard characterization aims to characterize a dose-effect relationship 
between the contaminant of interest and the biological effect identified in the hazard 
identification, in order for a human health-based guideline value to be derived. The 
guideline value is often defined as the NOAEL (no-observed adverse effect level) or 
the BMDL (the lower confidence interval of the benchmark dose).
55
 Assessment 
factors, also known as uncertainty factors or safety factors are applied to the NOAEL 
or BMDL, to account for uncertainties in the data such as differences in 
toxicokinetics and dynamics between experimental animals and humans.
56
 The aim of 
risk characterization is generally to compare the human health-based guideline values 
with exposure levels, estimated from the exposure assessment, in the population of 
interest to give an estimate of the occurrence and of the potential risks to the 
population.  
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2.3.1 Toxic equivalency factors  
Mixtures of PCBs and PCDD/Fs are assumed to have an additive effect. To 
facilitate risk assessment and regulatory control, the concept of toxic equivalency 
factors (TEFs) has been developed for those congeners whose chemical 
characteristics and toxic responses are similar to those of the most toxic dioxin, 
TCDD (Table 1). To be included in the TEF scheme, a congener must be; i) 
structurally related to TCDD, ii) bind to the AhR, iii) elicit AhR mediated biochemical 
and toxic responses, and iv) be persistent and accumulate in the food chain. By 
multiplying the concentration of each congener by its TEF value the toxic equivalent 
(TEQ) of a mixture can be calculated and the analytical results can be expressed as 
TEQ concentrations.
15
 TEF schemes from 1998
15
 and 2005
47
 initiated by the World 
Health Organization (WHO) have been used in the present thesis. 
 
 
 
2.3.2 Risk characterization of PCBs and PCDD/Fs 
2.3.2.1 Human health-based guidance values 
Several international expert groups within the WHO and the European Union have 
established human health-based guideline values for dioxins on the basis of 
toxicological studies on in utero exposure to TCDD in experimental animals.  
 
In 1998, the European Centre for Environment and Health (ECEH) and the 
International Programme of Chemical Safety (ICPS) reassessed the previous 
established tolerable daily intake (TDI) in humans of 10 pg TEQ/kg body weight. 
Based on new data on hormonal, reproductive, immunological and behavioral effects in 
offspring of rats and monkeys orally exposed to single and chronic doses of TCDD, the 
TDI was set to 1 - 4 pg TEQ/kg body weight using an uncertainty factor of 10, which 
was applied to the estimated body burden of the animals.
57
 The upper range was 
considered to be a maximal tolerable intake on a provisional basis and the ultimate goal 
was to reduce human intake levels below 1 pg/kg body weight.
57
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Table 1. Summary of WHO 1998 and WHO 2005 TEF values.  
Compound  WHO 1998 TEF  WHO 2005 TEF 
chlorinated dibenzo-p-dioxins 
2,3,7,8-TCDD  1  1 
1,2,3,7,8-PeCDD  1  1 
1,2,3,4,7,8-HxCDD  0,1  0,1 
1,2,3,6,7,8-HxCDD  0,1  0,1 
1,2,3,7,8,9-HxCDD  0,1  0,1 
1,2,3,4,6,7,8-HpCDD  0,01  0,01 
OCDD  0,0001  0,0003 
chlorinated dibenzofurans 
2,3,7,8-TCDF  0,1  0,1 
1,2,3,7,8-PeCDF  0,05  0,03 
2,3,4,7,8-PeCDF  0,5  0,3 
1,2,3,4,7,8-HxCDF  0,1  0,1 
1,2,3,6,7,8-HxCDF  0,1  0,1 
1,2,3,7,8,9-HxCDF  0,1  0,1 
2,3,4,6,7,8-HxCDF  0,1  0,1 
1,2,3,4,6,7,8-HpCDF  0,01  0,01 
1,2,3,6,7,8,9-HpCDF  0,01  0,01 
OCDF  0,0001  0,0003 
non-ortho substituted PCBs 
3,3',4,4'-tetraCB (PCB 77)  0,0001  0,0001 
3,4,4',5-tetraCB (PCB 81)  0,0001  0,0003 
3,3',4,4',5-pentaCB (PCB 126)  0,1  0,1 
3,3',4,4',5,5'-hexaCB (PCB 169)  0,01  0,03 
mono-ortho substituted PCBs 
2,3,3',4,4'-pentaCB (PCB 105)  0,0001  0,00003 
2,3,4,4',5-pentaCB (PCB 114)  0,0005  0,00003 
2,3',4,4',5-pentaCB (PCB 118)  0,0001  0,00003 
2',3,4,4',5-pentaCB (PCB 123)  0,0001  0,00003 
2,3,3',4,4',5-hexaCB (PCB 156)  0,0005  0,00003 
2,3,3',4,4',5'-hexaCB (PCB 157)  0,0005  0,00003 
2,3',4,4',5,5'-hexaCB (PCB 167)  0,00001  0,00003 
2,3,3',4,4',5,5'-heptaCB (PCB 189)  0,0001  0,00003 
Bold values indicate a change in TEF value between 1998 and 2005 
 
 
In 2001, JECFA (Joint FAO/WHO Expert Committee on Food Additives) established a 
provisional tolerable monthly intake (PTMI) in humans ranging from 40 - 100 pg 
TEQ/kg body weight. The PTMI was based on different modeling approaches using 
data on developmental effects in offspring of rats exposed to long-term subcutaneous 
dosing of TCDD, applying a safety factor of 9.6.
58
 The mid-point of 70 pg TEQ/kg 
body weight was chosen as the PTMI value (corresponding to a daily intake of 2.3 pg 
TEQ/kg body weight). 
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In 2000, the European Scientific Committee on Food (SCF) decided on a tolerable 
weekly intake (TWI) of 7 pg TEQ/ kg body weight corresponding to a TDI of 1 pg 
TEQ/kg body weight.
59
 After a re-evaluation of the pivotal studies one year later, the 
SCF decided upon a TWI of 14 pg TEQ/kg body weight (corresponding to a TDI of 2 
pg TEQ/kg body weight) based on developmental effects observed in offspring of rats 
orally exposed to a single dose of TCDD, and applying an uncertainty factor of 9.6.
60
 
The TWI is considered to be an estimate of a safe level of intake. 
 
 
In all aforementioned risk assessments, it is stated that the guideline values are not 
applicable to breastfed infants and the concept of the guideline values relates to a 
dietary intake throughout a lifetime whereby breastfeeding constitutes only a short 
period of that time. It is further stated that breast milk is thought to have beneficial 
effects on the child.  
 
 
In 2005, the European Food Safety Authority (EFSA) conducted a human health risk 
assessment for the sum of six non-dioxinlike PCBs (28, 52, 101, 138, 153, 180).
61
 No 
health-based guidance value was established because of limited toxicological data and 
difficulties in distinguishing the non-dioxinlike PCBs from the dioxinlike PCBs as well 
as other compounds in toxicological and epidemiological studies. EFSA concludes that 
there are indications that subtle developmental effects, caused by non-dioxinlike PCBs, 
dioxinlike PCBs, or PCDD/Fs alone, or in combination, may occur at maternal body 
burdens that are only slightly higher than those expected from the average daily intake 
in European countries.
61
 Because some individuals and some European (sub)-
populations may be exposed to considerably higher average intakes, a continued effort 
to lower the levels of non-dioxinlike PCBs in food was warranted.
61
 
  
A risk assessment of dioxins based on non-developmental effects has been performed 
by the Institute of Environmental Medicine (Karolinska Institutet, Sweden) and the 
Swedish NFA and relates to the general population.
62
 It was concluded that, based on 
carcinogenic effects in rodents, a TDI of 2-10 pg TEQ/kg body weight represents 
exposure levels where the human cancer risks are very low or non-existent.  
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2.3.2.2 Myocardial infarction and PCBs 
Besides from the developmental and carcinogenic health effects on which the risk 
assessments are based, PCBs and PCDD/Fs are also associated with cardiovascular 
effects.  
 
Myocardial infarction, often known as heart attack, is a state of change in the heart 
muscle. The myocardial tissue becomes subject to necrosis (cell death) caused by a 
blockage in circulating blood and thereby reduced oxygen supply. The reduced blood 
flow is most often the result of a blood clot surrounding a plaque rupture with 
thrombus formation in the vessel. The plaque development is often initiated by 
inflammatory responses.
63
   
 
There are several risk factors for cardiovascular diseases including diabetes, 
hypertension, hypercholesterolemia, dietary habits and life-style factors such as 
cigarette smoking and reduced physical activity.
64
 Long-chain n-3 polyunsaturated 
fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), 
have, on the other hand, a possible protective role against myocardial infarction.
65
 
Both EPA and DHA are present at higher concentrations in fatty fish (such as herring, 
mackerel and salmon) and in fish oil compared to other foods.
66
 However, fish can 
also contain high concentrations of contaminants especially PCBs, PCDD/Fs and 
methylmercury (MeHg).  
 
The role of PCB in the development of cardiovascular diseases is not known. The 
lining of the blood vessels consists of endothelial cells where an activation or 
dysfunction of the cells is a critical event in the initiation of cardiovascular diseases.
63
 
Experimental studies of PCB-exposed endothelial cells have shown increased cellular 
oxidative stress,
67
 CYP1A1 activity,
68
 poly (ADP-ribose) polymerase activity (PARP; 
DNA repair enzyme),
68
 induction of inflammatory transcription genes (cytokines and 
adhesion molecules),
69
 NADPH oxidase activity,
70
 and a disruption of the endothelial 
barrier function.
67
 The possible mechanisms of PCB cytotoxicity are illustrated in 
Figure 5. 
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Figure 5. A schematic view of possible mechanisms of PCB endothelial cytotoxicity. Modified 
picture from Hennig et al., 2005.
71
 
 
In animal studies of mice and rats, exposure to PCBs and/or PCDD/Fs was shown to 
cause increased blood pressure, serum cholesterol,
72
 expression of inflammatory 
adhesion molecules,
73
 markers of oxidative stress in aorta
74
 and heart weight
75
 as well 
as atherosclerosis
76
 and degenerative cardiovascular lesions including 
cardiomyopathy and chronic active arteritis.
77
 
 
Epidemiological studies investigating the association between PCB exposure and risk 
of cardiovascular diseases in the general population are few. A cross-sectional study 
on 463 American women (40 - 85 years of age) reported a statistically significant 
increased prevalence of self-reported CVD (coronary heart disease, angina, myocardial 
infarction and stroke) with increasing concentrations of several PCB congeners in 
serum.
78
 The multivariable-adjusted odds ratio in the highest as compared to the lowest 
quartile was 10.4 (95 % CI 1.1 – 94) for PCB153, 5.0 (95 % CI 1.2 – 20) for dioxin-
like PCBs and 3.8 (95 % CI 1.1 – 13) for non-dioxinlike PCBs.  
 
Most studies on cardiovascular diseases have been conducted on PCDD/Fs but these 
mainly include ecological, accidental and occupational studies, including a follow-up 
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study on residents living close to the industrial accident in Seveso (1976), where an 
increased risk was found between proximity to the industrial site and cardiovascular 
diseases such as chronic rheumatic heart diseases (rate ratio 5.7; 95% CI 1.8 – 18) but 
not for myocardial infarction.
27
 In a cross-sectional ecological study on residents 
living close to POP waste sites in New York, a 20% increase in rates of acute 
myocardial infarction was reported.
79
 In a prospective cohort study of 242 
occupationall- exposed Swedish men working at a manufacturing plant which used 
PCBs, a standardized mortality rate (SMR) of 1.44 (95 % CI 0.69 – 2.65) for 
circulatory diseases and a SMR of 1.49 (95 % CI 0.6 – 3.06) for ischemic heart disease 
was observed.
80
 The PCB exposure was estimated based on the men‟s working tasks. In 
a follow-up study of PCB-exposed workers, defined through a job exposure matrix 
and employed at one of two chemical plants in the U.S. between 1939 and 1977, a 
slight but non-significant increased risk of ischemic heart diseases was observed 
(SMR 1.07).
81
 In an extended study on PCB-exposed workers employed at any of the 
12 U.S. plants between 1942 and 1984, a standard mortality risk of 1.8 (95% CI 1.1 – 
2.9) was reported for ischemic heart diseases in the highest exposure category 
compared to the lowest.
82
 In an occupational cohort of workers at a chemical plant in 
Hamburg (Germany), the exposure to TCDD and PCDD/F, estimated from a 
validated kinetic model, showed a significant relative risk of 2.4 (95% CI 1.3 – 4.7) 
and 2.06 (95% CI 1.2 – 3.5), respectively, for ischemic heart diseases.83 Workers 
employed between 1969 and 1988 at a chemical plant in New Zeeland had an 
increased risk of ischemic heart diseases (SMR 1.10), however this was non-
significant.
84
 A international study by the International Agency for Research on 
Cancer comprising 36 occupational cohorts from 12 countries observed a rate ratio of 
1.67 (95% CI 1.23 – 2.26) for ischemic heart disease in TCDD-exposed workers.85 
 
Epidemiological studies of exposure to PCBs and PCDD/Fs in humans have also 
observed a statistically significant increased risk of established intermediate risk 
factors for cardiovascular diseases such as hypertension,
86,87
 hyperlipidemia,
88-90
 
atherosclerosis,
91
 metabolic syndrome
92
 and type 2 diabetes.
93,94
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3 Aim  
The overall aim of this thesis was to refine human exposure assessment by applying 
different methodological approaches for the purpose of characterizing the exposure to 
PCBs and PCDD/Fs in different subgroups of the general population. 
 
 
 
The more specific objectives were; 
 
 to characterize and compare the age and gender-specific, cumulative and long-
term PCB and PCDD/F exposure in different subgroups and risk groups using 
biomonitoring and different dietary exposure assessment methods (Paper I - 
IV) 
 
 to compare the deterministic and the probabilistic exposure assessment 
approach (Paper II) 
 
 to develop food concentration databases for the assessment of food frequency 
questionnaire-based estimates of concurrent and long-term dietary PCB153 
exposure (Paper III and IV) 
 
 to validate and apply food frequency questionnaires in a large population-
based prospective cohort study for assessment of the association between 
dietary PCB153 exposure and risk of myocardial infarction (Paper III and 
IV) 
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4 Subjects and Methods 
4.1 Study populations and data sources 
A short summary of the study design of the different papers is presented in Figure 6.  
Here follows a general description of the different data sources used in this thesis.  
 
 
4.1.1 The nationwide dietary and household budget survey 
For this thesis, data on children‟s and young adults‟ dietary consumption was obtained 
from a nationwide dietary and household budget survey that was carried out by the 
Swedish NFA in collaboration with the Statistics Sweden in 1989.
95
 The study 
population was systematically selected from a registry of the total population in 
Sweden sorting residents into different districts, thereby, guaranteeing an even 
geographical distribution.
95
 The inclusion criteria for the study population were 
individuals between 1 - 74 years of age (born 1915 - 1989), who lived in a household 
where every member shared a common household economy, and who were not 
institutionalized. An invitation to participate was sent out to 2,937 eligible subjects and 
70% participated. Of these, 953 were boys/men and girls/women between 1 - 24 years 
of age. The response rate for this group was73% (Figure 6).
95
 
 
One member of each household received a questionnaire on age, weight, dietary 
habits, major life-style factors and medical history. Each member also received a 7-
day menu diary listing frequently consumed foods and pre-specified serving sizes, in 
terms of cups, pieces, slices, teaspoons, or by using portion guides of photographed 
meals. The participants reported their consumption of foods during breakfast, lunch 
and dinner by filling in the number of portions of the relevant food(s) listed. In-
between meal eating occasions and foods not already listed were recorded as free text. 
The participants recorded their daily food consumption for one week starting at 
different time points during the year.
95
 Young children filled in the menu diary with 
the help of their parents and by personnel at day care centers. The individuals were 
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divided into six age groups; 1 - 3, 4 - 6, 7 - 10, 11 - 14, 15 - 18 and 19 - 24 years.
95
 
Complete data were available for 670 boys/men and girls/women 1 to 24 years of age.  
 
The most commonly consumed food items were collected from producers or 
purchased from two different stores in each of four major cities in Sweden (Uppsala, 
Göteborg, Malmö and Sundsvall) and analyzed during 1998–1999.35,96 Each food 
item was weighed and homogenized.
96
 Food items were collected again and analyzed 
between 2000 and 2004.
35,97
 A combination of the 1998/1999 and 2000/2004 data sets 
were used in the present thesis.  
 
Seventeen PCDD/F congeners together with nine PCB congeners (77, 105, 114, 118, 
126, 156, 157, 167 and 169) were analyzed in all food items. The analyses were 
performed at Umeå University, Dr. Wessling laboratorien in Germany, and at the 
Swedish NFA. The chemical analyses of food items during 2000–2004 were 
performed on all the aforementioned contaminants and an additional PCB congener 
(81). The TEQ values were based on the TEF-scheme from 1998 and values below 
the limit of quantification (LOQ) have been substituted with a value that is half of this 
limit at the Swedish NFA.
96
  
 
 
 
4.1.2 The time-trend investigation on pollutants in breast milk 
Breast milk concentration data as well as personal characteristics of Swedish mothers 
were obtained in a time-trend investigation on pollutants in breast milk performed 
within the National Health Related Environmental Monitoring Program run by the 
Swedish Environmental Protection Agency and carried out by the Swedish NFA.
98
 
First-time mothers who were Swedish by birth and delivered at Uppsala University 
Hospital between 2000 and 2006 were recruited.
98
 First-time mothers were recruited in 
order to minimize the variation in contaminant levels due to parity. Women, who 
delivered during the first week in every month and on randomly selected days during 
this week, were asked to participate in the time-trend investigation. Every month, 2 - 3 
mothers were recruited (Figure 6). The mothers sampled milk at home during the third 
week after delivery (approximately 14 - 21 days postpartum) using a manual breast 
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milk pump and/or a passive breast milk sampler.
98
 The women were instructed to 
sample milk both at the beginning and at the end of the breastfeeding session. The goal 
was to sample 500 ml milk from each mother during 7 days of sampling. The breast 
milk was stored in the home freezer, in acetone-washed bottles. Newly sampled milk 
was poured on top of the frozen milk. At the end of the sampling week, a mid-wife 
visited the mothers to collect the bottles. Data on age and weight were obtained via 
questionnaires completed approximately 6 weeks after delivery.  
 
Individual breast milk concentration data for each congener of both dioxinlike and non-
dioxinlike PCBs (mono-ortho substituted congeners 28, 105, 118, 156 and 167, di-ortho 
substituted congeners 52, 101, 138, 153 and 180, and non-ortho congeners 77, 126 and 
169) as well as for PCDD/Fs (sixteen congeners) were obtained from the Swedish 
NFA.
98
 Di-ortho, mono-ortho and non-ortho PCBs, with the exception of non-ortho 
PCBs in samples from 2006, were analyzed at the Swedish NFA, whereas PCDD/Fs 
(2000 to 2004) were analyzed at the National Institute of Public Health and the 
Environment (the Netherlands; RIVM) and PCDD/Fs and non-ortho PCBs from 2006 
were analyzed at the Department of Chemistry at Umeå University in Sweden.
98
  
The LOQ for mono- and di-ortho PCBs, non-ortho PCBs and PCDD/Fs was 0.23 - 1.3 
ng/g, 11 - 39 pg/g and 0.04 - 4.0 pg/g milk fat, respectively. The percentage of values 
below LOQ varied from 3 to 71% with fewer values below LOQ in 2006. 
Concentrations of PCBs and PCDD/Fs in breast milk had been adjusted for the lipid 
concentrations in the biological media at the Swedish NFA.
98
  
 
 
 
4.1.3 The Swedish Mammography Cohort 
Data on food consumption in middle-aged and elderly women were obtained from the 
Swedish Mammography Cohort (SMC), a population-based prospective cohort study of 
women established between 1987 and 1990.
99
 The source population consisted of 
90,303 women who were born between 1914 and 1948 and who lived in central 
Sweden (Uppsala County and Västmanland County; response rate 74%; Figure 6). The 
women received a mailed invitation, together with a 67-item food frequency 
questionnaire (FFQ) and personal characteristics (e.g., age, weight, parity and 
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education), to participate in a free mammography screening program.
99
 To update and 
expand exposure data, a second questionnaire was sent out in 1997 to all 56,030 
eligible cohort members still living in the study area (response rate 70%).
100
 The 
questionnaire from 1997 gathered additional information on diet (a 96-item FFQ), 
medical history and major life-style factors (including smoking status, physical activity 
and use of dietary supplements).
100
 From November 2003 to August 2009, 5,022 
women from the cohort (60 % response rate), still living in the town of Uppsala, 
participated in a health examination during which they donated blood and completed a 
questionnaire containing a 123-item FFQ.
101
 Of these women, we included the first 201 
consecutive women that completed the FFQ in 1997 and again in 2004 - 2006 at the 
time of the health examination for the validation of the FFQ. The 201 women were 
non-users of fish oil supplements to avoid influence of additional sources of PCB 
exposure.
102
 Of those women, 165 filled in the same questionnaire again one year later, 
2005-2007 (hereafter referred to as the reproducibility study).
103
 
 
The FFQs from 1997 and 2004-2006 primarily reflected the women's average 
consumption of different foods and beverages during the previous year and were 
based on open-ended questions with pre-specified serving sizes for frequently 
consumed foods (i.e., dairy products) and eight predefined frequency categories 
(never, 1 - 3 times/month, 1 - 2, 3 - 4 and 5 - 6 times/week, and 1, 2 or 3 or more 
times/day).
100
 Questions on seafood comprised of grouped fish, i.e., high fat fish 
(Atlantic herring, Baltic Sea herring, and mackerel), medium fat fish (Arctic char, 
salmon and whitefish) and low fat fish (cod, saithe and pollock), as well as one 
question each regarding consumption of caviar and shellfish. Compared to the 1997-
FFQ, the later FFQ also contained questions on other fish and tuna, and three 
additional frequency questions on dairy and meat products. Age-specific portion sizes 
had been estimated from 5,922 weighed food records kept by 213 randomly selected 
women from the study area.  
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Figure 6. Study design of Papers I – IV. 
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For a construction of a food database, concentration data of PCB153 in food available 
on the Swedish market was obtained from the regular control and monitoring program 
run by the Swedish NFA. Concentrations of triglycerides and cholesterol were analyzed 
at Uppsala University Hospital, whereas phospholipids were analyzed at Karolinska 
University Hospital. 
 
PCB congeners (118, 138, 153, 156, 170 and 180) in serum from 201 women were 
analyzed at the National Institute for Health and Welfare in Finland.
104
 None of the 
analytical results were below the LOQ which varied from 2 to 5 pg/ml serum. 
 
 
 
 
4.2 Mathematical exposure modeling and statistical analysis  
In Paper I, a simple distribution approach was used to estimate the exposure to PCBs 
and PCDD/Fs in different age groups. The dietary exposure expressed as TEQ values 
was calculated by multiplying individual food consumption level with mean 
concentration data of the contaminants in various foods. Food consumption data were 
available for all 670 individuals expressed both in fresh (ng/day) and lipid (g fat/day) 
weight. The food items were assigned to food groups; dairy products, meat and meat 
products, fish and fish products, egg and other fat containing food products. Analysis 
of covariance (ANCOVA) using post-hoc test Scheffe (p < 0.05) was used for 
comparing mean estimates of TEQ exposure in different food groups and over all 
food groups between different age-groups and sex.  
 
In Paper II, the deterministic and the probabilistic approach were compared for the 
estimation of exposure to PCBs and PCDD/Fs in breastfed infants. Values below 
LOQ were substituted with half of this limit for the deterministic calculations, 
whereas the MLE method was used for the probabilistic exposure calculations. Total 
TEQ as well as PCB-TEQ and PCDD/F-TEQ were estimated by multiplying the 
concentrations of each congener with their respective TEF value using the TEF-
scheme from 2005.
47
 Probabilistic exposure calculations were performed using a 
Monte Carlo simulation where each simulation contained 25 000 iterations after which 
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variations in parameters were assumed to be negligible. Non-parametric bootstrap 
sampling was used to estimate the uncertainty of the calculated probabilistic exposure 
estimations expressed as confidence intervals using 100 trials and 2000 iterations. The 
maximum likelihood method was used for fitting a Hill model to the daily milk 
consumption data, which was assumed to be normally distributed. Parameters for 
residue concentration data were also estimated with the maximum likelihood approach, 
where a log-normal distribution was fitted to the concentration data and the likelihood 
of values above and below the detection limit was optimized so that under the detection 
limit the predicted fraction of the total likelihood was approximately the same as the 
observed fraction of values below detection limit. Generalized mixed effect models 
using population-average mixed effect spline models were used for temporal trend 
analysis avoiding multicollinearity between the continuous variables.  
 
For the purpose of calculating exposure to PCBs in a prospective population-based 
cohort, a large recipe-based database was created from concentrations of PCB153 in 
different food items retrieved from the time period between 1992 and 2009 (Paper 
III and IV). The concentration data was extrapolated to reflect the levels of PCB153 
in food between the years 1997 and 2004, assuming an 8% yearly decline in PCB153 
concentrations. This figure is based on samples of breast milk in Sweden
98
 as well as 
in swine and bovine adipose tissue sampled at slaughter houses in Sweden.
32
 If 
sufficient concentration data for a specific food item was available for the analytical 
years 1997 or 2004 then these values were preferred over the extrapolated values. In 
total, over 1,200 samples were used for the concentration data of which 12% of the 
samples had a value below LOQ. Values below LOQ were substituted with half of 
this limit. A large recipe-based database was also created for methylmercury (MeHg) 
included 1,353 fish samples analyzed between 1975 and 2007 with no obvious 
observed temporal trend. 
 
Concentration data for serum PCB153 in 201 women was used for validating the FFQ 
(Paper III) which was subsequently used in Paper IV. An intra-class correlation 
coefficient was calculated to measure the strength of agreement between dietary 
PCB153 exposures estimated from two identical FFQs in the reproducibility study by 
assessing the proportion of the between-person variance to the total variance, i.e., the 
sum of both the within- and between-variation. Serum PCB concentrations were 
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divided by total serum lipid concentrations and expressed as ng/g lipid. Total serum 
lipid was calculated according to Grimvall and colleagues (1997) based on assumed 
molecular weights for triglycerides, phospholipids and cholesterol of 807, 571 and 
714 u, respectively, and a proportion of free and esterified cholesterol in plasma 
1:2.
105
  Spearman‟s rank correlation coefficient (rs) and 95% confidence intervals (CI) 
were used to measure the strength of the relationship between FFQ-based dietary 
PCB153 exposure and serum concentrations of PCB congeners. De-attenuated 
Spearman‟s correlation coefficient was used to account for the reproducibility by 
adjusting the Spearman‟s correlation coefficient with the intraclass correlation 
coefficient. Agreement of cross-classification was used to measure the proportion of 
subjects classified into the same or adjacent category of exposure.  
 
In Paper IV, the association between validated FFQ-based dietary PCB153 exposure 
and risk of myocardial infarction was studied in 33,638 women. The women were 
followed from mid-September (1997) until the date of first myocardial infarction, death 
or end of follow-up (31 December 2008), whichever came first. We categorized women 
into quartiles of dietary PCB153 exposure at baseline. Hazard ratios (HR) and 95% CI 
were estimated using Cox proportional hazards regression models with attained age (in 
years) as the underlying timescale. In the multivariable-adjusted analysis, we adjusted 
for level of education (<10, 10–12, or >12 y), family history of myocardial infarction 
before the age of 60 years (yes/no), high cholesterol (yes/no), hypertension (yes/no), 
ever use of postmenopausal hormones (yes/no), use of aspirin (yes/no), smoking status 
(never, past or current), waist circumference (≤ 80/> 80 cm), weight loss of ≥5 kg 
within a year (yes/no), parity, ever use of fish oil supplements (yes/no), total physical 
activity (MET-h; quartiles), history of atrial fibrillation before 1997 (yes/no), alcohol 
intake (0; > 0 - 4.9; 5.0 - 14.9; >15.0 g/day), energy intake (continuous, kcal/day), 
dietary MeHg exposure (quartiles; μg/day) and consumption of fruit and vegetables 
(quartiles; g/day), meat (quartiles; g/day) and sum of EPA and DHA (quartiles; g/day). 
The Schoenfeld‟s residual test showed no indications of violation of the proportional 
hazard assumption. A linear trend across categories was tested using median dietary 
PCB153 values within categories as a continuous variable. To test for possible 
interactions, the likelihood ratio test was used to compare models with and without an 
interaction term of dietary PCB153 (quartiles) and waist circumference (≤ 80/> 80 cm) 
and parity (nulliparous/≥1 child).  
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All statistical analyses were either performed in PASW/SPSS for Windows (SPSS Inc., 
version 18.0, California, USA) or STATA (STATA Corp. Inc., version 11, Texas, 
USA). Probabilistic exposure calculations were performed in Crystal Ball
®
 
(Decisioneering Inc. Release 11.1.1.3.0) and the MLE method was performed using the 
statistical software R (version R 2.6.2, Wirtshaftsuniversität, Wien, Austria). Reported 
p values were from two-sided statistical tests where a p value of ≤0.05 was considered 
statistically significant. 
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5 Results and Discussion 
This section summarizes the main results of the present thesis along with a discussion 
regarding different exposure assessment approaches and methodological 
considerations. For a detailed description of the results, the reader is referred to the 
separate papers (Paper I - IV). 
  
 
 
 
5.1 Estimating variability in exposure using different approaches  
There is a general lack of knowledge in the variability of exposure to PCBs and 
PCDD/Fs in different age and sex subgroups of the general population. Through 
the use of the simple distribution approach and the probabilistic approach, detailed 
estimates of the exposure to dioxinlike PCBs and PCDD/Fs (expressed as TEQ 
values) in different subgroups of the Swedish population was obtained based on a 
menu diary and contaminant concentrations in food (Paper I) as well as 
biomonitoring data (Paper II; Figure 7). 
 
The estimated exposure to dioxinlike PCBs and PCDD/Fs per kilo body weight 
decreased from early infancy (median 44 pg/kg body weight in 1 month old infants) to 
adulthood (median 1.4 pg/kg body weight; Figure 7). The variability in exposure 
between individuals was large and resulted in 22 – 26% of young adults and 3% of 
first-time mothers exceeding the recommended TDI of 2 pg TEQ/kg bw (Paper I and 
II). Because of the high exposure during infancy and early childhood, infants and  
1-10 year old children had a median dietary exposure that exceeded, by far, the TDI 
(Paper I). There was a statistically significant difference (p < 0.05) between children 
of younger and older age groups in their exposure to PCBs and PCDD/Fs. There was 
no difference between boys and girls within the same age group, except for girls in 
the 19 – 24 year age group who had a significantly lower exposure from meat 
products compared to boys of the same age group (Paper I).  
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Figure 7. Dietary exposure to dioxinlike PCBs and PCDD/Fs in different subgroups of the 
Swedish population. Each box represents the 25th percentile (bottom), the median value 
(middle) and the 75th percentile (top). The line represents a TDI value of 2 pg TEQ/kg body 
weight. 
 
The cumulative body burden in infants was 4 times higher (4.8 to 20 ng TEQ) at 
the end of 6 months of breastfeeding for dioxinlike PCBs and PCDD/Fs and 7 
times higher (46 to 352 mg) for the non-dioxinlike PCBs compared to the initial 
exposure at the start of the breastfeeding period (Paper II). 
 
 
 
General discussion about the levels of PCBs and PCDD/Fs 
An age-dependent decrease in exposure levels has also been observed in 
populations from the Netherlands,
34
 Spain,
106
 Italy,
107
 and the U.S.,
108
 and is partly 
explained by the higher consumption of food by children relative to their body 
weight compared to adults. Children between 1 to 6 years of age eat about 3 times 
more food on a body weight basis than the average adult (Paper I). Even though 
the dietary exposure to PCBs and PCDD/Fs decreases by age due to an increase 
in body weight, the cumulative body burden of these contaminants increases with 
age.
51,109
 In the present thesis, there was a 4 to 7 fold increase in mean cumulative 
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exposure to dioxinlike PCBs and PCDD/Fs during 6 months of breastfeeding 
(Paper II) as also observed in Dutch infants.
109
    
 
The number of individuals exceeding the current TDI of 2 pg TEQ/kg body weight
60
 
decreased from almost 100% of infants and young children to less than 4% of first-
time mothers (Figure 7). The current TDIs are not applicable to breastfed infants 
because of the short duration of this life period and the assumed overall beneficial 
effects of breastfeeding on child development.
57,58,60
 However, results from studies on 
the association between exposure to PCBs and PCDD/Fs and the health effects of 
breastfeeding are contradictory.
110-113
 Furthermore, risks appearing in adulthood due 
to high exposure early in life are unknown, although it seems that the exposure during 
early infancy has an impact on body burden later in adulthood.
52
 Swedish women 
who were themselves breastfed had higher concentrations of PCBs and PCDD/Fs in 
breast milk compared to women who had not been breastfed.
52
 Early life is a 
vulnerable stage of development which means that children are a special risk group 
and, thus, more studies are needed to disentangle the potential effects of relatively 
high exposure during a sensitive period in life to improve risk assessments.
114
 
 
The current TDIs are based on prenatal effects and thus mainly concerns pregnant 
women and women of childbearing age. Of these women, 3 – 4% had dietary exposure 
levels of dioxinlike PCBs and PCDD/Fs that were close to the upper range of the TDI 
value (4 pg TEQ/kg body weight). The upper TDI value is only 3.5 times lower than 
the most sensitive end point in animals (14 pg TEQ/kg body weight). It may be 
discussed whether or not the safety margin (uncertainty factor) of ten is large enough to 
compensate for this narrow range. The potential health risks of such an exposure level 
is difficult to predict, however, due to the narrow safety margin efforts to continue 
reducing the exposure is essential to avoid potential adverse health effects in children.  
 
The TDI of 2 – 8 pg TEQ/kg body weight based on carcinogenic effects is applicable 
for consumers of the general population and was also exceeded by many of the 
individuals in the present thesis.
62
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Methodological considerations  
The dietary exposure to PCBs and PCDD/Fs was based on consumption data from 
a menu diary (covering 7 consecutive days) and contaminant concentrations in 
food. Menu diaries are similar to dietary records in the sense that the respondents 
have to fill in how much of their food is consumed on a daily basis.
3
 In comparison 
to dietary records, the menu diary contains a food list that the respondent can 
choose from.  
 
Variability in the exposure levels to PCBs and PCDD/Fs (Paper I) is probably, to 
some extent, reflected by the choice of dietary assessment method (menu diary) 
since the consumption of foods was recorded on a daily basis rather than as an 
average consumption covering a longer period as estimated from FFQs.
3
 For this 
reason, seasonal differences in exposure will also have an effect on the exposure 
estimated from menu diaries.
115
 The menu diary in the present study, did not 
always note the origin of the fish or what type of fish that was consumed by the 
individuals and, thus, Baltic Sea fish including salmon and herring containing high 
concentrations of the contaminants could have had a stronger, or less marked, 
impact on the exposure estimate.
116
 Furthermore, the menu diary covered a 
relatively short period and does not represent the entire lifetime exposure of a 
child. In the present thesis, the estimated daily exposure to PCBs and PCDD/Fs in 
mother, based on breast milk concentration data, was comparable to those 
estimated from dietary questionnaires,
97
 indicating that exposure estimations based 
on biomonitoring data could be a good alternative when food consumption data are 
not available or are of low quality. 
 
Concentrations of PCBs and PCDD/Fs in breast milk were adjusted for the lipid 
content in milk to avoid influence due to temporal variability
117
 and inter-individual 
differences (where two women with similar body burden of PCBs and PCDD/Fs but 
different breast milk lipid contents would otherwise be misclassified).  
 
The exposure to dioxinlike PCBs and PCDD/Fs were estimated based on two different 
TEF schemes; one from 1998 and one from 2005 (Paper I and II). In the revised 
version of the TEF scheme, the authors conclude that the TEQ value (derived from 
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applying a TEF value to the concentrations in food or biota) decreased with 10 – 45% 
when using the revised TEF scheme from 2005 compared to the TEF scheme from 
1997.
47
 The largest decrease in TEQ was observed for chicken (- 45%) followed by 
Baltic herring (- 25%), and may lead to the erroneous impression that the dietary 
exposure to PCBs and PCDD/Fs (expressed as TEQ) has decreased.
118,119
 
 
 
 
5.2 Comparing exposure assessment approaches 
Reliable human exposure data is needed for effective risk assessment and management. 
By applying a probabilistic exposure assessment approach to the exposure data, true 
individual variations in exposure are taken into account, and thus, overly conservative 
exposure estimates based on deterministic exposure assessment approaches can be 
avoided. For this reason, the probabilistic exposure assessment approach was used for 
estimating infant exposure at different time points during breastfeeding as well as the 
daily exposure in nursing mothers based on biomonitoring data, and compared to the 
deterministic approach. 
 
The estimated mean exposure to PCBs and PCDD/Fs was comparable when using the 
deterministic and the probabilistic exposure assessment approach; a mean exposure of 
44 pg TEQ/kg body weight in 1 month old infants when using either approach was seen 
(Paper II). The estimated worst case scenario, on the other hand, was 1.25 times higher 
for dioxinlike PCBs and PCDD/Fs and 1.67 times higher for non-dioxinlike PCBs 
when using the deterministic worst case scenario approach compared to the 95
th
 
percentile from the probabilistic exposure distribution (Figure 8; Paper II). The 
sensitivity analysis showed that fat content and breast milk consumption were the 
variables with the greatest influence on the variation of exposure in the probabilistic 
model contributing to 63% and 19%, respectively. In total, 9 of the 25 input variables 
(9 PCBs and 16 PCDD/Fs) contributed to the variance of the exposure (0.1 – 11%) 
whereas the rest of the 16 input variables had very little effect on the variability of the 
exposure distribution.  
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Figure 8. Comparing mean values (♦) and 95th percentiles (|) of exposure to dioxinlike PCBs 
and PCDD/Fs expressed as TEQ (A) and non-dioxinlike PCBs (B) in 1 month old breastfed 
infants using the probabilistic and the deterministic exposure assessment approach. 
 
 
 
General discussion and methodological considerations  
So far, the deterministic exposure assessment approach including the worst case 
exposure scenario has been the dominating methodology within exposure assessments. 
However, probabilistic modeling, including benchmark dose modeling and 
physiologically based toxicokinetic modeling, is increasingly being used to improve 
exposure and health risk assessments.
120,121
 The point estimates that are used within the 
worst case scenario calculations are by definition conservative, which may tend to 
result in an overestimation of the exposure.
122
 The probabilistic approach, on the other 
hand, is more practical because several upper-bound percentiles can be drawn from the 
same exposure distribution where a range of possible exposure scenarios are presented, 
and the likelihood of these exposures to occur is given.
8
 
 
An accurate exposure distribution from the probabilistic model is derived by using 
probability density functions that give a good representation of the different input 
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variables. However, finding a distribution that best represents the input data can be 
difficult since the distributions are often based on empirical data to which several 
distributions may fit, especially when the collected sample size is small.
123
 For 
example, the skewness of a distribution based on collected empirical data can affect the 
central tendency of the output.
8
 It should be noted, however, that the choice of 
distribution is less important than the precision of the mean and variance estimates. 
Hence, based on results from sensitivity analyses, special attention should be put on the 
variables that have the greatest impact on the variance of the exposure outcome. For 
instance, increasing the mean of the input variable of fat content in a probabilistic 
model will equally increase the mean of the exposure.
124
  
 
In conclusion, the deterministic approach should be considered as a first tier in human 
exposure assessments using the worst case approach to protect public health. The 
probabilistic approach, on the other hand, can be used to increase the accuracy of the 
exposure and to gain more information such as probability of risk levels, sensitivity 
analysis, uncertainty and variability analysis.  
 
In Paper II, values below the quantification limit (censored data) were replaced by 
one-half of this limit or by using the MLE method. Assigning censored data with a 
value can result in an overestimation, whereas the opposite can occur if censored data 
are assigned with the value zero or neglected.
9
 To minimize the bias in over- and 
underestimation of the exposure, the one-half of the quantification limit can be used 
assuming, however, that all values between the quantification limit are equally likely. 
The degree to which the results are biased will depend on the values below the 
quantification limit in relation to those above the limit.  
 
 
 
5.3 Use of food contaminant databases for exposure assessment 
In Paper I, concentration data for the different food items was considered constant 
between the analytical years 1998 - 2004 and no time-trend adjustments were therefore 
made to the concentrations in food. When calculating the total TEQ exposure, the 
difference between in TEQ exposure by using concentration data in food analyzed from 
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1998 to 1999 rather than food concentration data analyzed from 2000 to 2004, was only 
0.18%, which was based on the sum of TEQ values in food items analyzed during the 
two periods (1998–1999 and 2000–2004).  
 
For Paper III and IV, two large recipe-based databases for PCB153 were 
constructed for the FFQs completed in 1997 and 2004-2006. The concentration 
data for PCB153 was extrapolated by 8% per year
98
 to reflect the concentrations in 
food during the years 1997 and 2004-2006. The number is based on time-trend 
studies of PCB concentrations in breast milk.
98
 In Paper II, the temporal decrease 
in concentrations of PCBs and PCDD/Fs in breast milk between 2004 and 2006 
were minor (41 versus 40.5 pg TEQ/kg body weight, respectively) and, thus, the 
food concentration data for year 2004 to 2006 was assumed to be the same. There 
is of course an amount of uncertainty in the two databases, including the 
standardized recipes and the extrapolation factor for the concentration data. The 
percentage of decrease in PCB153 concentrations may not be the same for all 
foods.
125
 Food analyzed in the years 1997 or 2004 were used as far as possible to 
avoid this problem.  
 
The dietary databases were created for PCB153 as an indicator for PCB and 
PCDD/F exposure.
126
 In the present thesis, PCB153 was the most abundant 
congener in breast milk and serum, accounting for 42 - 46% of the total 
concentrations of PCBs and PCDD/Fs in breast milk (Paper II and III). Serum 
concentrations of PCB153 correlated well with five other PCB congeners (118, 
138, 156, 170 and 180; rs 0.72 – 0.94; p value <0.001) as well as with the total sum 
of the PCB congeners (rs 0.93; Paper III). Similar correlations were observed in 
breast milk between PCB153 and eight other PCB congeners (118, 138, 156, 157, 
167, 169, 170 and 180; rs 0.69 – 8.89; p value <0.001) as well as with 10 out of 15 
of the PCDD/Fs congeners (rs 0.53 – 0.78; p value <0.05). 
 
For the two food contaminant databases, the concentrations of PCB153 below the 
quantification limit were replaced with one-half of this limit (12% of the total number 
of samples). When comparing different approaches, that is, replacing censored data 
with one-half of the quantification limit, replacing censored data with zero and 
replacing censored data with square root of the quantification limit, in samples of dairy 
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products, the mean concentration of PCB153 was the same between the three 
approaches. The influence of the various methods for dealing with the censored data 
was minor because of the low number of data below the quantification limit.
9
  
 
 
 
5.4 Validating food frequency questionnaires  
Validated FFQs for estimating dietary exposure to PCBs can be used in large 
prospective epidemiological studies for studying the association between exposure and 
risk of health effects, thereby overcoming the disadvantages of high costs of sample 
collection and chemical analyses of biomarkers as well as cross-sectional study designs. 
 
In Paper III, the validation of FFQs for estimating concurrent (median 152 ng/day 
~ 2.2 ng/kg bw) as well as long-term (7 to 9 years prior to blood sampling; 169 
ng/day ~ 2.4 ng/kg body weight) exposure assessment of PCB153 was based on 
concentrations in serum PCBs (118, 138, 153, 156, 170 and 180) in middle-aged 
and elderly women (n = 201; 48 – 83 years of age). The intra-class correlation 
coefficient was 0.51 based on FFQ-estimated exposure to PCB153 in the 
reproducibility study (median 153 ng/day in 2004 –2006 and 160 ng/day in  
2005 – 2007; n = 165).  
 
A reasonable validity was observed between FFQ-based dietary estimates of 
PCB153 exposure (expressed as ng/kg body weight and day) and age- and lipid-
adjusted concentrations in serum PCB153. The deattenuated Spearman correlation 
coefficient was 0.37 (p value <0.001) for the concurrent exposure assessment and 
0.32 (p value <0.05) for the long-term exposure assessment (Paper III). The 
correlation for the five other PCB congeners (118, 138, 156, 170 and 180) in serum 
ranged from 0.26 to 0.45 (95% CI; 0.06-0.62) and 0.23 to 0.42 (95% CI 0.00-0.62) 
for the respective exposure assessments. 
 
The degree of cross-classification of tertiles of serum PCB153 levels was evaluated 
against tertiles of the 2004-06 FFQ-estimated PCB153 exposures. In the lowest tertile 
of serum PCB153, 32 of 67 women (48 %) had low levels of both serum PCB153 and 
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concurrent dietary PCB153 exposure (corresponding results were 51 % for serum 
sumPCB). In the highest tertile of serum PCB153, 39% of the women were categorized 
into the same dietary category (the same results were obtained for serum sumPCB). 
Very similar results were obtained for the 1997 FFQ-estimated PCB153 exposure. The 
percentage of women classified into the same or adjacent tertile was 85 % for both the 
1997 and the 2004-2006 FFQ.  
 
 
 
General discussion and methodological considerations 
We obtained a reasonable validity of the FFQ justifying the use of the FFQ for 
estimating dietary PCB exposure. The dietary PCB153 exposure compares well to the 
estimated exposure in middle-aged and elderly women in Sweden.
127
 
 
The FFQ-estimated PCB153 exposure was compared to the concentrations of PCB 
congeners in serum, presumed to represent long-term exposure to PCBs. Previous 
studies have found a strong correlation between concentrations of lipid-adjusted PCBs 
in serum and PCBs in adipose tissue,
50,128
 the main storage site for life-long 
accumulation of polychlorinated pollutants.
129
 The correlation between FFQ-based 
estimates of PCB exposure and serum PCB concentrations was stronger when adjusting 
the dietary exposure for body weight and the serum concentrations for age. The reason 
for this could be that the amount of PCB in serum is not equivalent to the amount of 
PCB ingested when expressed as g/day as would be observed in individuals with a 
larger body size. Instead, the larger the body weight, the more PCB is concentrated in 
the fatty tissues.
130
 The mean PCB153 concentrations in blood of Swedish women 50 – 
74 years of age increased by 1.8% per year of age
131
 and was a strong predictor of body 
burden of PCBs.
105,132
 Adjusting serum PCB concentrations for age may compensate 
for the cumulative serum concentrations.  
 
In the present thesis, serum had been sampled once after a 12-hour overnight fast and 
adjusted for the serum lipid content. Sampling after fasting reduces the influence of diet 
on the concentrations of PCBs in serum,
133
 especially if the dietary concentration is 
higher than that in blood.
134
 Thus, changes in serum PCB concentrations over time can 
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be compensated for if the PCB concentrations are reported on a lipid weight basis 
rather than on a fresh weight basis.
133
 The serum lipid concentrations, in the present 
thesis, had been determined by the enzymatic method and, hence, the weight of the 
lipid content was calculated based on the method described by Grimvall and co-
workers.
105
 In the study by Grimvall, the correlation between the enzymatic method 
and the gravimetric method for determining serum lipids was 0.82.
105
  
     
 
 
 
5.5 Exposure levels and associations with myocardial infarction 
Through the use of validated FFQs for estimating PCB153 exposure, the risk of 
myocardial infarction was estimated in middle-aged and elderly women (Figure 9). An 
increased hazard ratio of 1.67 (95% CI 1.17 – 2.40) was observed for total myocardial 
infarction in the highest exposure quartile of dietary PCB153 exposure (median 280 
ng/day) compared to those in the lowest (median 98 ng/day) in the multivariable-
adjusted model (Paper IV). The hazard ratio was even more pronounced (2.62; 95% CI 
1.15 – 5.98) for fatal myocardial infarction (Figure 9).  
 
 
 
Figure 9. Multivariable-adjusted hazard ratios (95% confidence intervals) of any first 
myocardial infarction (MI) according to quartiles of dietary PCB153 exposure in 33,638 
women. 
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General discussion and considerations 
The strong correlation between PCB153 and other congeners of PCBs and PCDD/Fs 
hinders the possibility to make conclusions about a causal relationship. However, it 
has been suggested that since PCB congeners act differently in relation to predicting 
factors (e.g., BMI) they should not be considered to be assessed as a homogenous 
group in exposure assessments. Cell culture and animal studies support the theory of 
PCB exposure and associations with CVD as well as risk factors for CVD.
68,69,71,77
 
Paper IV is based on a prospective epidemiological study design in which exposure is 
estimated prior to the diagnosis of disease and, thus, reverse causality can be avoided. 
 
Fish and seafood can also contain high concentrations of methylmercury (MeHg).
135
 
Adjusting for MeHg exposure was important to rule out the possibility of observing 
effects on myocardial infarction caused by MeHg exposure. Epidemiological 
findings behind the cardiovascular effects of MeHg are inconsistent. Of seven 
studies, 
136
 
137
 
138
 
139
 
140
 only two have shown an increased risk of coronary heart 
diseases associated with toenail mercury concentrations
141
 and concentrations of 
mercury in hair.
142
 
 
 
 
5.6 Dietary sources of PCBs and PCDD/Fs exposure and risk of myocardial 
infarction 
One important aspect of exposure assessment is source identification. Once the pattern 
of exposure in highly exposed individuals or individuals at risk is characterized, public 
health polices can then be developed such as dietary recommendations and tolerable 
intakes. Through dietary questionnaires and databases on contaminants in food, the 
major dietary sources of exposure could be estimated in different age and risk groups in 
the present thesis.     
 
Fish and dairy products were in general the main sources of exposure in children and 
young adults accounting for 29% and 30 %, respectively, of the total TEQ exposure 
(Figure 10; Paper I). On the other hand, fish and fish products were in general the main 
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sources of exposure in the highly exposed children and young adults contributing with 
75% to the total dietary exposure. Fish and fish products were the main source of 
exposure to PCB153 in middle-aged and elderly women accounting for 66 – 78% of the 
total exposure (Paper III). 
 
 
 
 
 
Figure 10. Contribution from food groups to the estimated exposure to dioxinlike PCBs and 
PCDD/Fs in Swedish children and young adults 1-24 years (A; average and B; highly exposed 
(95
th
 percentile), and to PCB153 in middle-aged and elderly women (C; 1997 and D; 2004 - 
06). 
 
 
When taking into account the beneficial effects of long-chain polyunsaturated fish fatty 
acids that is eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), the hazard 
ratio for myocardial infarction was 2 times higher (95% CI 1.25 to 3.94) in women in 
the highest quartile of dietary PCB153 exposure at the same time having a low intake 
of EPA and DHA (< 0.20 g/day), compared to those in the lowest quartile having a 
high intake of more than 0.29 g/day of EPA and DHA (Figure 11; Paper IV). 
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Figure 11. Multivariable-adjusted hazard ratios of myocardial infarction according to quartiles 
of dietary PCB153 exposure (ng/day) and intake of EPA and DHA (g/day). 
 
 
 
General discussion 
Even though fish in general contain higher concentrations of PCBs and PCDD/F than 
other food, dairy products were the main source of exposure in children and young 
adults from the present thesis. The reason for this is the relatively higher consumption 
of dairy products compared to fish and fish products. During recent years, the 
importance of different food exposure sources has changed, resulting in a higher 
contribution from fish and fish products to the total exposure in children.
143,144
 In 
Sweden, 
127
 and in some other countries,
36-39
 fish and fish products are the main dietary 
contributors to the exposure to PCBs and PCDD/Fs in adults. The higher contribution 
from fish in middle-aged women as compared to children and adolescents is probably 
due to a higher consumption of fish in this subpopulation.
41
 
 
Fish is also the major source of long-chain n-3 polyunsaturated fatty acids (n-3 
PUFAs) which is suggested to have a protective effect on CVD
145,146
 and to 
improve mental development and cognition in infants and young children.
147
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Health risk analyses of PCBs in relation to the beneficial effects of n-3 PUFAs in 
fish, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are 
limited in number.
148
 Hence, there remain difficulties in determining the 
appropriate dietary recommendations for consumption of fatty fish since these both 
pose a risk to the population from exposure to PCBs and PCDD/Fs and a potential 
health benefit derived from omega-3 fatty acids.
149,150
 Only during recent years 
have the exposure to contaminants and the intake of nutrients from fish (and other 
foods) been considered together, i.e., risk-benefit analyses, when establishing 
dietary recommendations.
151
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6 CONCLUSIONS 
I. Reliable exposure estimates of PCBs and PCDD/Fs in various age groups was 
achieved by the use of different exposure assessment approaches, taking into 
account variability and uncertainty in exposure data.  
 
II. Age specific exposure assessments that consider sensitive and/or highly 
exposed individuals in the general population is a prerequisite for effective risk 
management. 
 
III. The deterministic (worst case) exposure assessment approach should be 
considered as the first choice while the use of the more sophisticated 
approaches such as the probabilistic approach should be utilized when more 
detailed exposure information is needed. 
 
IV. Highly exposed individuals were characterized by a high fish consumption 
independent of age. Thus, continued actions are needed to reduce 
environmental levels and at the same time conduct risk-benefit analysis for 
efficient dietary recommendations. 
 
V. A reasonable validity of FFQ-based PCB153 exposure estimates in relation to 
PCB concentrations in serum was obtained, justifying the use of FFQs in large 
scale epidemiological studies. 
 
VI. FFQ-estimated dietary PCB153 exposure was associated with increased risk of 
myocardial infarction among women. Further studies are needed to elucidate 
the observed association between the indicator biomarker PCB153 and risk of 
cardiovascular effects. 
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